| Literature DB >> 22057033 |
Nicholas Hatzirodos1, Julie Nigro, Helen F Irving-Rodgers, Aditya V Vashi, Katja Hummitzsch, Bruce Caterson, Thomas R Sullivan, Raymond J Rodgers.
Abstract
To examine the detailed composition of glycosaminoglycans duringEntities:
Mesh:
Substances:
Year: 2011 PMID: 22057033 PMCID: PMC3657699 DOI: 10.1016/j.matbio.2011.10.002
Source DB: PubMed Journal: Matrix Biol ISSN: 0945-053X Impact factor: 11.583
Comparison of the saccharide concentrations (pmoles per μg DNA) of theca cells versus granulosa cells combining all follicle types examined.
| Saccharides | Abbreviations | Cell type | *p-value | ||||
|---|---|---|---|---|---|---|---|
| Granulosa | Theca | ||||||
| Median | Inter-quartile Range | Median | Inter-quartile Range | ||||
| Chondroitin saccharides | ∆uronic acid with | ∆Di0S | 0.0 | 0.0 | 5.2 | 7.0 | 0.001 |
| ∆uronic acid with | ∆Di4S | 5.4 | 7.8 | 39.0 | 31.2 | 0.021 | |
| ∆uronic acid with | ∆Di6S | 6.6 | 6.9 | 20.1 | 9.6 | 0.001 | |
| ∆uronic acid with | ∆Di4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.375 | |
| ∆Di2,4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.500 | ||
| Hyaluronan saccharide | ∆uronic acid with | ∆DiHA | 0.0 | 0.5 | 4.8 | 9.7 | 0.219 |
| † Heparan saccharides | ∆uronic acid with | ΔU-G-NAc | 1.3 | 1.8 | 2.5 | 2.0 | <.001 |
| ∆uronic acid with | ΔU-G-NS | 0.0 | 0.1 | 0.6 | 1.2 | <.001 | |
| ∆uronic acid with | ΔU-G(6S)-NAc | 0.0 | 0.0 | 0.0 | 0.0 | 0.570 | |
| ∆uronic acid with | ΔU-G-(6S)-NS | 0.0 | 0.0 | 0.0 | 0.4 | 0.055 | |
| ΔU(2S)-G-NS | 0.0 | 0.0 | 0.0 | 0.4 | 0.006 | ||
| ΔU(2S)-G(6S)-NS | 0.0 | 0.0 | 0.4 | 0.6 | < 0.001 | ||
*Wilcoxon signed rank test.
† Number of observations is n = 24 except for the HS saccharides where n = 36.
Fig. 1Examples of fluorophore-assisted carbohydrate electrophoresis identifying saccharides following enzymatic digestion of theca interna isolated from both healthy and atretic follicles of different sizes (small, medium and large) with either (A) hyaluronidase SD and chondroitinase ABC or (B) heparinase and heparitinase I and II. In (A) glucose, maltose, maltotriose and maltotetraose which are not the products of hyaluronidase SD and chondroitinase ABC digestions are also visible. In each gel sacharide standards (Std) and a control without sample but still reacted with 2-aminoacridone (Blank) were included. The abbreviated names of each saccharide are listed in full in Table 1. An equivalent amount of each sample containing 3 μg of DNA was loaded per lane.
Comparison of the saccharide concentrations (pmoles per μg DNA) in granulosa cells from small, medium and large-sized follicles.
| Saccharides | Follicle Size | |||||||
|---|---|---|---|---|---|---|---|---|
| Small | Medium | Large | *p-value | |||||
| Median | Inter-quartile Range | Median | Inter-quartile Range | Median | Inter-quartile Range | |||
| Chondroitin saccharides | ∆Di0S | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.000 |
| ∆Di4S | 1.5 | 4.3 | 5.7 | 6.6 | 7.5 | 24.3 | 0.019 | |
| ∆Di6S | 5.9 | 8.1 | 6.2 | 7.3 | 7.2 | 5.6 | 0.992 | |
| ∆Di4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.8 | 0.109 | |
| ∆Di2,4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.000 | |
| Hyaluronan saccharide | ∆DiHA | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 2.6 | 0.398 |
| † Heparan saccharides | ΔU-G-NAc | 0.0 | 1.6 | 1.8 | 1.7 | 1.2 | 0.3 | 0.027 |
| ΔU-G-NS | 0.0 | 0.0 | 0.1 | 0.5 | 0.0 | 0.1 | 0.017 | |
| ΔU-G(6S)-NAc | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.061 | |
| ΔU-G-(6S)-NS | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.075 | |
| ΔU(2S)-G-NS | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.858 | |
| ΔU(2S)-G(6S)-NS | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.550 | |
* Kruskal Wallis test.
† Number of observations is n = 8 except for HS saccharides where n = 12.
Comparison of the saccharide concentrations (pmoles per μg DNA) in granulosa cells from healthy and atretic follicles.
| Saccharides | Health | |||||
|---|---|---|---|---|---|---|
| Healthy | Atretic | *p-value | ||||
| Median | Inter-quartile Range | Median | Inter-quartile Range | |||
| Chondroitin saccharides | ∆Di0S | 0.0 | 0.0 | 0.0 | 0.0 | 1.000 |
| ∆Di4S | 4.1 | 3.8 | 10.7 | 24.5 | 0.022 | |
| ∆Di6S | 5.8 | 5.6 | 7.7 | 7.5 | 0.207 | |
| ∆Di4,6S | 0.0 | 0.0 | 0.0 | 1.7 | 0.048 | |
| ∆Di2,4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 1.000 | |
| Hyaluronan saccharide | ∆DiHA | 0.0 | 0.0 | 0.0 | 2.1 | 0.082 |
| † Heparan saccharides | ΔU-G-NAc | 0.0 | 1.2 | 1.6 | 1.0 | 0.001 |
| ΔU-G-NS | 0.0 | 0.0 | 0.0 | 0.4 | 0.061 | |
| ΔU-G(6S)-NAc | 0.0 | 0.0 | 0.0 | 0.3 | 0.025 | |
| ΔU-G-(6S)-NS | 0.0 | 0.0 | 0.0 | 0.1 | 0.080 | |
| ΔU(2S)-G-NS | 0.0 | 0.0 | 0.0 | 0.1 | 0.251 | |
| ΔU(2S)-G(6S)-NS | 0.0 | 0.0 | 0.0 | 0.3 | 0.013 | |
*Wilcoxon test.
† Number of observations is n = 12 except for the HS saccharides where n = 18.
Comparison of the saccharide concentrations (pmoles per μg DNA) in thecal cells from healthy and atretic follicles.
| Saccharides | Health | |||||
|---|---|---|---|---|---|---|
| Healthy | Atretic | *p-value | ||||
| Median | Inter-quartile Range | Median | Inter-quartile Range | |||
| Chondroitin saccharides | ∆Di0S | 5.4 | 7.1 | 5.0 | 7.0 | 0.816 |
| ∆Di4S | 38.1 | 19.7 | 45.7 | 38.6 | 0.323 | |
| ∆Di6S | 21.4 | 10.6 | 18.7 | 9.7 | 0.797 | |
| ∆Di4,6S | 0.0 | 0.0 | 0.0 | 0.5 | 0.338 | |
| ∆Di2,4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.179 | |
| Hyaluronan saccharide | ∆DiHA | 2.6 | 10.6 | 5.1 | 9.0 | 0.700 |
| † Heparan saccharides | ΔU-G-NAc | 1.9 | 1.3 | 3.0 | 2.1 | 0.013 |
| ΔU-G-NS | 0.0 | 0.9 | 0.7 | 2.2 | 0.054 | |
| ΔU-G(6S)-NAc | 0.0 | 0.0 | 0.0 | 0.5 | 0.072 | |
| ΔU-G-(6S)-NS | 0.0 | 0.2 | 0.4 | 0.4 | 0.045 | |
| ΔU(2S)-G-NS | 0.0 | 0.2 | 0.2 | 0.8 | 0.030 | |
| ΔU(2S)-G(6S)-NS | 0.3 | 0.5 | 0.5 | 0.7 | 0.122 | |
*Wilcoxon test.
† Number of observations n = 12 except for the HS saccharides where n = 18.
Comparison of the saccharide concentrations (pmoles per μg DNA) in thecal cells from small, medium and large-sized follicles.
| Saccharides | Follicle Size | |||||||
|---|---|---|---|---|---|---|---|---|
| Small | Medium | Large | *p-value | |||||
| Median | Inter-quartile Range | Median | Inter-quartile Range | Median | Inter-quartile Range | |||
| Chondroitin saccharides | ∆Di0S | 5.3 | 4.0 | 1.4 | 5.4 | 7.3 | 9.8 | 0.161 |
| ∆Di4S | 39.0 | 27.6 | 31.8 | 30.3 | 47.0 | 23.4 | 0.213 | |
| ∆Di6S | 23.6 | 11.7 | 15.9 | 6.3 | 21.4 | 17.5 | 0.033 | |
| ∆Di4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.742 | |
| ∆Di2,4,6S | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.593 | |
| Hyaluronan saccharide | ∆DiHA | 5.5 | 5.1 | 0.0 | 7.4 | 3.8 | 12.8 | 0.522 |
| † Heparan saccharides | ΔU-G-NAc | 2.3 | 1.8 | 1.9 | 1.0 | 3.7 | 1.2 | 0.001 |
| ΔU-G-NS | 0.4 | 1.3 | 0.2 | 0.7 | 0.8 | 2.0 | 0.236 | |
| ΔU-G(6S)-NAc | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.019 | |
| ΔU-G-(6S)-NS | 0.1 | 0.4 | 0.0 | 0.0 | 0.4 | 0.3 | 0.002 | |
| ΔU(2S)-G-NS | 0.1 | 0.5 | 0.0 | 0.0 | 0.4 | 0.5 | 0.001 | |
| ΔU(2S)-G(6S)-NS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.001 | |
*Kruskal Wallis test.
† Number of observations is n = 8 except for the HS saccharides where n = 12.
Fig. 2Localization of 3C5, 4C3 and 7D4 CS epitopes in early and small antral follicles. (A) Early antral follicle stained with H&E (g = membrana granulosa, arrow = arteriole). (B) Same follicle as shown in panel A with 3C5 (red) localized to the stromal connective tissue around the follicle and von Willebrand factor indicating blood vessels (green) (arrow = arteriole). (C, D) Combined immunostaining of 7D4 (green) and laminin 111 (red) of an early antral follicle (panel C) and a small antral follicle (panel D). 7D4 is localized to the stromal connective tissue surrounding the early antral follicle (panel C) and laminin 111 is localized to the follicular basal lamina (arrow) and capillary sub-endothelial basal laminas (double headed arrows). In the small antral follicle (panel D) 7D4 (green) is localized to the theca interna (g = membrana granulosa, arrow = follicular basal lamina, DAPI staining of nuclei in blue). (E) Small antral follicle stained with H&E. The specialized connective tissue layers surrounding antral follicles consist of the theca interna (black double-headed arrow) and theca externa (white double-headed arrow) (g = membrana granulosa). (F, G, H) Same follicle as shown in E. 3C5 (red, panel F), 4C3 (red, panel G), 7D4 (red, panel H) localize to the theca interna adjacent to the follicular basal lamina and blood vessels are identified by localization of von Willibrand factor (green). Bars = 20 μm.
Fig. 3Localization of 3C5, 4C3, 7D4 and 3B3(+) CS epitopes to vessels in the theca externa of large antral follicles and the ovarian medulla. (A) Section of a large antral follicle stained with H&E showing a large vessel (asterisk) at the boundary of the theca interna (ti) and theca externa, the membrana granulosa (g) and a small vessel in the theca externa (arrow). (B, C, D) Serial sections of the area shown in panel A. 3C5 (red, panel B), 4C3 (red, panel C) and 7D4 (red, panel D) localize to the vessels identified by staining with von Willebrand factor (green). The arrow indicates a small vessel in the theca externa and the asterisk a large blood vessel as also identified in panel A. (E) Section of a large antral follicle stained with H&E showing a large vessel (asterisk) in the theca externa. (F) Same section as panel E localizing 3B3(+) (red) and von Willebrand factor (green) around a large blood vessel (asterisk) as also identified in panel E. (G, H, I) Localization of LYVE-1 (red) and of 4C3 (green in G), 7D4 (green in H, I) in the theca externa of large antral follicles (G, H) and ovarian medulla (I). (J) Section of a similar region of the ovarian medulla to that shown in panel I stained with H&E and identifying a lymphatic vessel (asterisk) and an area with aterioles (triangle). (K) A large arteriole in the ovarian medulla stained with H&E. ( L) Serial section of the arteriole in panel K localizing 3B3(+) (red) to the muscularis layer and von Willebrand factor (green) identifying the endothelium. (M) 7D4 (green) localization to the muscularis (red, smooth muscle actin) of a large arteriole in the ovarian medulla. Bars = 20 μm.
Fig. 4Immunolocalization of CS epitope recognized by 2B6 (red in A-C, G, H) and versican (red in D-F, J, K) in stroma (A, D), early antral follicles (B, E) and antral follicles (C, F, G, H, J-L). CS epitope recognized by 2B6 (A) and versican (D) are localized to the connective tissue stroma surrounding arterioles (asterisks) in the ovarian medulla. In early antral follicles CS epitope 2B6 (B) and versican (E) are localized to the membrana granulosa (g) and theca interna (ti). In antral follicles CS epitope recognized by 2B6 (C, G, H) and versican (F, J, K) are localized to the membrana granulosa (g), the cumulus cells (c) and not the oocyte (O). CS epitope 2B6 (G) and versican (J) are also localized to the theca interna (ti) and form a layer abutting the follicular basal lamina (CS epitope 2B6: C, H; and versican: K). CYP17, a marker of thecal cells, is localized to the theca interna (green in G and H) and laminin (green in J and K) is localized to the follicular basal lamina (arrow) and capillary sub-endothelial basal laminas in the theca interna (ti). Inter-α-trypsin inhibitor (green in L) localizes to the theca interna but does not co-localise with 7D4 (red). (I), H&E, serial section to (G) and (J). Bars = 20 μm (A, D, F-K) and 50 μm (B, C, E, L).